Oropharyngeal Candidiasis Completed Phase 4 Trials for Fluconazole (DB00196)

IndicationStatusPhase
DBCOND0038453 (Oropharyngeal Candidiasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00553137Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in TanzaniaTreatment